Blackhawk Capital Partners’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$7.87M Buy
6,563
+35
+0.5% +$35.8K 2.57% 11
2026
Q1
$6M Sell
6,528
-7
-0.1% -$7.1K 2.2% 11
2025
Q4
$7.02M Buy
6,535
+9
+0.1% +$8.61K 2.64% 10
2025
Q3
$4.98M Sell
6,526
-2,024
-24% -$1.51M 1.94% 13
2025
Q2
$6.67M Buy
8,550
+34
+0.4% +$26.4K 3.07% 7
2025
Q1
$7.03M Buy
8,516
+2,504
+42% +$2.08M 3.62% 4
2024
Q4
$4.64M Buy
6,012
+756
+14% +$626K 2.4% 8
2024
Q3
$4.66M Buy
5,256
+41
+0.8% +$36.9K 2.49% 6
2024
Q2
$4.72M Buy
5,215
+335
+7% +$268K 2.85% 6
2024
Q1
$3.8M Buy
4,880
+20
+0.4% +$14.2K 2.37% 6
2023
Q4
$2.83M Buy
4,860
+601
+14% +$351K 1.92% 14
2023
Q3
$2.29M Hold
4,259
1.67% 20
2023
Q2
$2M Hold
4,259
1.39% 29
2023
Q1
$1.46M Hold
4,259
1.07% 36
2022
Q4
$1.56M Hold
4,259
1.22% 30
2022
Q3
$1.38M Hold
4,259
1.14% 36
2022
Q2
$1.38M Hold
4,259
1.08% 37
2022
Q1
$1.22M Hold
4,259
0.83% 50
2021
Q4
$1.18M Hold
4,259
0.71% 55
2021
Q3
$984K Hold
4,259
0.62% 58
2021
Q2
$796K Hold
4,259
0.54% 67
2021
Q1
$719K Sell
4,259
-25
-0.6% -$4.89K 0.54% 63
2020
Q4
$634K Hold
4,284
0.54% 56
2020
Q3
$703K Sell
4,284
-625
-13% -$96.7K 0.64% 51
2020
Q2
$681K Hold
4,909
0.81% 49
2020
Q1
$645K Hold
4,909
0.58% 55
2019
Q4
$549K Hold
4,909
0.55% 56
2019
Q3
$549K Sell
4,909
-1,300
-21% -$145K 0.51% 59
2019
Q2
$688K Hold
6,209
0.66% 52
2019
Q1
$806K Hold
6,209
0.83% 43
2018
Q4
$719K Hold
6,209
0.92% 42
2018
Q3
$666K Hold
6,209
0.94% 35
2018
Q2
$530K Hold
6,209
0.6% 47
2018
Q1
$480K Hold
6,209
0.41% 58
2017
Q4
$524K Buy
+6,209
New +$528K 0.45% 61

Other funds holding LLY

Blackhawk Capital Partners's LLY Position: Q2 2026 in Review

Blackhawk Capital Partners increased its Eli Lilly (LLY) stake by 0.54% in Q2 2026, buying an estimated $35.8K and bringing the position to 6,563 shares worth $7.87M. The position accounts for 2.57% of the portfolio, ranked #11.

Blackhawk Capital Partners first reported a position in LLY in Q4 2017 and has held it in 35 quarters since. 1,600 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Blackhawk Capital Partners held 6,563 shares of Eli Lilly worth $7.87M as of Q2 2026.
  • Blackhawk Capital Partners bought 35 Eli Lilly shares in Q2 2026, an estimated $35.8K.
  • Eli Lilly made up 2.57% of Blackhawk Capital Partners's portfolio in Q2 2026, its #11 holding.
  • Blackhawk Capital Partners first reported a position in Eli Lilly in Q4 2017 and has held it in 35 quarters since.
  • 1,600 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Blackhawk Capital Partners's 13F filing for Q2 2026, filed 20 Jul 2026.